Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2012 1
2014 1
2016 1
2017 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Mild traumatic brain injury.
Vos PE, Alekseenko Y, Battistin L, Ehler E, Gerstenbrand F, Muresanu DF, Potapov A, Stepan CA, Traubner P, Vecsei L, von Wild K; European Federation of Neurological Societies. Vos PE, et al. Among authors: alekseenko y. Eur J Neurol. 2012 Feb;19(2):191-8. doi: 10.1111/j.1468-1331.2011.03581.x. Eur J Neurol. 2012. PMID: 22260187 Free article.
Guidelines for Quality Management of Apallic Syndrome / Vegetative State.
von Wild K, Gerstenbrand F, Dolce G, Binder H, Vos PE, Saltuari L, Alekseenko Y, Formisano R, Ritz A, Ortega-Suhrkamp E, Jörg JR, Potapov AA, León-Carrión J, Vilcinis R, Zitnay GA. von Wild K, et al. Among authors: alekseenko y. Eur J Trauma Emerg Surg. 2007 Jun;33(3):268-92. doi: 10.1007/s00068-007-6138-1. Epub 2007 Apr 21. Eur J Trauma Emerg Surg. 2007. PMID: 26814491
Report of the Task Force on pre-graduate education in Europe of the education committee of the European Federation of Neurological Societies Composition of the task force of the education committee on pre-graduate education.
Lopes Lima JM, Mesec A, Wilkinson IM, Wiles CM, Gilhus NE, Zimprich F, Alekseenko YV, Grisold W; European Federation of Neurological Societies. Lopes Lima JM, et al. Among authors: alekseenko yv. Eur J Neurol. 2008 Dec;15(12):e103-9. doi: 10.1111/j.1468-1331.2008.02364.x. Eur J Neurol. 2008. PMID: 19049532
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group. Confavreux C, et al. Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23. Lancet Neurol. 2014. PMID: 24461574 Clinical Trial.